Clinical trial
Anerning Particle for Reducing the Application of Antibiotics of Childhood Community-acquired Pneumonia: a Randomized, Double Blind, Control of Placebo, Multi-center Clinical Study
NCT03675178 is registered in ClinicalTrials.gov with China Academy of Chinese Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anerning Particle for Reducing the Application of Antibiotics of Childhood Community-acquired Pneumonia: a Randomized, Double Blind, Control of Placebo, Multi-center Clinical Study
- Lead sponsor
- China Academy of Chinese Medical Sciences
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 22, 2018
- Completion date
- December 31, 2019
- Enrollment
- 216 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.